2BBBullish & Bearish
BlossomHill Therapeutics Inc (BLSM) trades on NASDAQ. It operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry. Its current 2BB score is 46 out of 100.
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D., and biotech business veteran, Y.
BlossomHill Therapeutics Inc’s current 2BB score is 46 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 55 | Moderate |
| Momentum | 37 | Weakening |
| Financial strength | 39 | Weak |
| Quality | 75 | Strong |
| Risk | 71 | High (provisional) |
| Founded | 2020 |
| Employees | 69 |
| 52-week range | $14.76 – $27.99 |